ProText Mobility (OTC: TXTM)
$0.00
(27.8%)
$0.00
Price as of April 26, 2024, 3:59 p.m. ET
ProText Mobility Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
ProText Mobility Company Info
ProText Mobility, Inc. engages in the development of pharmaceutical applications for botanical drugs. It has license to develop Phytofare, which is a bioavailable extract produced from live green tea leaves that has been clinically proven in double-blind human trials to have ten-times greater bioavailability over generic extract. The company was founded on September 5, 2001 and is headquartered in Miami, FL.
News & Analysis
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.